Home LiteratureArticle Details
PMID: 21829357 Published · ppublish English Journal Article Research Support, N.I.H., Extramural

EBV latency types adopt alternative chromatin conformations.

PLoS pathogens ·Vol. 7 ·No. 7 ·2011-07-00 ·Pages e1002180

Tempera I, Klichinsky M, Lieberman PM

Abstract

Epstein-Barr Virus (EBV) can establish latent infections with distinct gene expression patterns referred to as latency types. These different latency types are epigenetically stable and correspond to different promoter utilization. Here we explore the three-dimensional conformations of the EBV genome in different latency types. We employed Chromosome Conformation Capture (3C) assay to investigate chromatin loop formation between the OriP enhancer and the promoters that determine type I (Qp) or type III (Cp) gene expression. We show that OriP is in close physical proximity to Qp in type I latency, and to Cp in type III latency. The cellular chromatin insulator and boundary factor CTCF was implicated in EBV chromatin loop formation. Combining 3C and ChIP assays we found that CTCF is physically associated with OriP-Qp loop formation in type I and OriP-Cp loop formation in type III latency. Mutations in the CTCF binding site located at Qp disrupt loop formation between Qp and OriP, and lead to the activation of Cp transcription. Mutation of the CTCF binding site at Cp, as well as siRNA depletion of CTCF eliminates both OriP-associated loops, indicating that CTCF plays an integral role in loop formation. These data indicate that epigenetically stable EBV latency types adopt distinct chromatin architectures that depend on CTCF and mediate alternative promoter targeting by the OriP enhancer.

MeSH Terms
CCCTC-Binding Factor Cell Line Chromatin/genetics,metabolism,virology Chromatin Assembly and Disassembly Enhancer Elements, Genetic/genetics Herpesvirus 4, Human/physiology Humans Promoter Regions, Genetic/genetics Repressor Proteins/genetics,metabolism Transcription, Genetic Virus Latency/physiology
Chemicals
CCCTC-Binding Factor CTCF protein, human Chromatin Repressor Proteins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Tempera Italo
The Wistar Institute, Philadelphia, Pennsylvania, United States of America.
Klichinsky Michael
Lieberman Paul M
References (69)
69 references, click to expand
  1. CTCF mediates interchromosomal colocalization between Igf2/H19 and Wsb1/Nf1.
    Science. 2006 Apr 14;312(5771):269-72 PMID: 16614224
  2. The three 'C' s of chromosome conformation capture: controls, controls, controls.
    Nat Methods. 2006 Jan;3(1):17-21 PMID: 16369547
  3. CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease.
    Blood. 1996 Oct 15;88(8):3129-36 PMID: 8874213
  4. An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes.
    Mol Cell Biol. 1996 Jun;16(6):2802-13 PMID: 8649389
  5. Chromatin profiling of Epstein-Barr virus latency control region.
    J Virol. 2007 Jun;81(12):6389-401 PMID: 17409162
  6. Epstein-Barr virus and carcinomas: undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus.
    J Pathol. 1991 Sep;165(1):17-24 PMID: 1659626
  7. CTCF mediates long-range chromatin looping and local histone modification in the beta-globin locus.
    Genes Dev. 2006 Sep 1;20(17):2349-54 PMID: 16951251
  8. Chromatin insulators: regulatory mechanisms and epigenetic inheritance.
    Mol Cell. 2008 Oct 10;32(1):1-9 PMID: 18851828
  9. Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection.
    Proc Natl Acad Sci U S A. 1991 May 1;88(9):3942-6 PMID: 1850841
  10. Overproduction, purification, and characterization of EBNA1, the origin binding protein of Epstein-Barr virus.
    J Biol Chem. 1991 Apr 25;266(12):7819-26 PMID: 1850421
  11. Autorepression of Epstein-Barr virus nuclear antigen 1 expression by inhibition of pre-mRNA processing.
    J Virol. 2008 Feb;82(4):1679-87 PMID: 18077719
  12. CTCF: master weaver of the genome.
    Cell. 2009 Jun 26;137(7):1194-211 PMID: 19563753
  13. Differential methylation of Epstein-Barr virus latency promoters facilitates viral persistence in healthy seropositive individuals.
    J Virol. 1999 Dec;73(12):9959-68 PMID: 10559309
  14. EBV persistence in memory B cells in vivo.
    Immunity. 1998 Sep;9(3):395-404 PMID: 9768759
  15. Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma.
    Int J Cancer. 1988 Sep 15;42(3):329-38 PMID: 2843473
  16. Differential hyperacetylation of histones H3 and H4 upon promoter-specific recruitment of EBNA2 in Epstein-Barr virus chromatin.
    J Virol. 2003 Jul;77(14):8166-72 PMID: 12829856
  17. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease.
    Lancet. 1991 Feb 9;337(8737):320-2 PMID: 1671232
  18. The CTCF insulator protein is posttranslationally modified by SUMO.
    Mol Cell Biol. 2009 Feb;29(3):714-25 PMID: 19029252
  19. An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene.
    J Virol. 1995 Apr;69(4):2633-6 PMID: 7884916
  20. Mediator and cohesin connect gene expression and chromatin architecture.
    Nature. 2010 Sep 23;467(7314):430-5 PMID: 20720539
  21. A novel form of Epstein-Barr virus latency in normal B cells in vivo.
    Cell. 1995 Feb 24;80(4):593-601 PMID: 7532548
  22. The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell.
    Immunity. 2000 Oct;13(4):497-506 PMID: 11070168
  23. Multiple EBNA1-binding sites are required to form an EBNA1-dependent enhancer and to activate a minimal replicative origin within oriP of Epstein-Barr virus.
    J Virol. 1989 Jun;63(6):2657-66 PMID: 2542579
  24. Epstein-Barr virus gene expression in nasopharyngeal carcinoma.
    J Gen Virol. 1988 May;69 ( Pt 5):1051-65 PMID: 2836550
  25. Epigenotypes of latent herpesvirus genomes.
    Curr Top Microbiol Immunol. 2006;310:61-80 PMID: 16909907
  26. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes.
    J Virol. 1992 Jan;66(1):122-31 PMID: 1309242
  27. Chromatin insulators: lessons from the fly.
    Brief Funct Genomic Proteomic. 2009 Jul;8(4):276-82 PMID: 19752045
  28. A novel sequence-specific DNA binding protein which interacts with three regularly spaced direct repeats of the CCCTC-motif in the 5'-flanking sequence of the chicken c-myc gene.
    Oncogene. 1990 Dec;5(12):1743-53 PMID: 2284094
  29. Epstein-Barr virus exploits BSAP/Pax5 to achieve the B-cell specificity of its growth-transforming program.
    J Virol. 2007 Sep;81(18):10092-100 PMID: 17626071
  30. Telomere repeat binding factors TRF1, TRF2, and hRAP1 modulate replication of Epstein-Barr virus OriP.
    J Virol. 2003 Nov;77(22):11992-2001 PMID: 14581536
  31. Telomeric proteins regulate episomal maintenance of Epstein-Barr virus origin of plasmid replication.
    Mol Cell. 2002 Mar;9(3):493-503 PMID: 11931758
  32. Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease.
    Int J Cancer. 1996 Nov 4;68(3):285-90 PMID: 8903467
  33. Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma.
    J Virol. 1990 Oct;64(10):4948-56 PMID: 2168978
  34. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus.
    J Gen Virol. 1989 Nov;70 ( Pt 11):2989-3002 PMID: 2479717
  35. Epstein-Barr virus: 40 years on.
    Nat Rev Cancer. 2004 Oct;4(10):757-68 PMID: 15510157
  36. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines.
    Proc Natl Acad Sci U S A. 1995 Nov 7;92(23):10565-9 PMID: 7479841
  37. Multiple regions within EBNA1 can link DNAs.
    J Virol. 1995 Oct;69(10):6199-208 PMID: 7666521
  38. Methylation of the EBV genome and establishment of restricted latency in low-passage EBV-infected 293 epithelial cells.
    Virology. 2002 Jul 20;299(1):109-21 PMID: 12167346
  39. Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes.
    Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14188-93 PMID: 16966603
  40. Epigenetics of latent Epstein-Barr virus genomes: high resolution methylation analysis of the bidirectional promoter region of latent membrane protein 1 and 2B genes.
    Biol Chem. 2001 Apr;382(4):699-705 PMID: 11405234
  41. Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein.
    J Virol. 1996 Jan;70(1):623-7 PMID: 8523583
  42. Epstein-Barr virus-associated gastric adenocarcinoma.
    Am J Pathol. 1992 Apr;140(4):769-74 PMID: 1314023
  43. Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes.
    J Virol. 1992 Jun;66(6):3715-24 PMID: 1316478
  44. Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes.
    Proc Natl Acad Sci U S A. 1990 Mar;87(5):1725-9 PMID: 2155423
  45. Nuclear organization of the genome and the potential for gene regulation.
    Nature. 2007 May 24;447(7143):413-7 PMID: 17522674
  46. Epstein-Barr virus in the pathogenesis of NPC.
    Semin Cancer Biol. 2002 Dec;12(6):431-41 PMID: 12450729
  47. CTCF controls expression and chromatin architecture of the human major histocompatibility complex class II locus.
    Mol Cell Biol. 2010 Sep;30(17):4211-23 PMID: 20584980
  48. trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1.
    Mol Cell Biol. 1986 Nov;6(11):3838-46 PMID: 3025615
  49. DNA methylation and the Epstein-Barr virus.
    Semin Cancer Biol. 1999 Oct;9(5):369-75 PMID: 10547345
  50. CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease.
    Trends Genet. 2001 Sep;17(9):520-7 PMID: 11525835
  51. Poly(ADP-ribosyl)ation regulates CTCF-dependent chromatin insulation.
    Nat Genet. 2004 Oct;36(10):1105-10 PMID: 15361875
  52. Dynamic genome architecture in the nuclear space: regulation of gene expression in three dimensions.
    Nat Rev Genet. 2007 Feb;8(2):104-15 PMID: 17230197
  53. ORC binding to TRF2 stimulates OriP replication.
    EMBO Rep. 2006 Jul;7(7):716-21 PMID: 16799465
  54. Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF.
    J Virol. 2006 Jun;80(12):5723-32 PMID: 16731911
  55. Epstein-Barr virus immortalizing genes.
    Trends Microbiol. 1995 Mar;3(3):105-9 PMID: 7773587
  56. oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines.
    J Virol. 1996 Sep;70(9):5758-68 PMID: 8709191
  57. Gene regulation through nuclear organization.
    Nat Struct Mol Biol. 2007 Nov;14(11):1049-55 PMID: 17984967
  58. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state.
    J Virol. 1994 Nov;68(11):7374-85 PMID: 7933121
  59. Does CTCF mediate between nuclear organization and gene expression?
    Bioessays. 2010 Jan;32(1):37-50 PMID: 20020479
  60. CTCF prevents the epigenetic drift of EBV latency promoter Qp.
    PLoS Pathog. 2010 Aug 12;6(8):e1001048 PMID: 20730088
  61. Capturing chromosome conformation.
    Science. 2002 Feb 15;295(5558):1306-11 PMID: 11847345
  62. Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2.
    Nat Med. 2002 Oct;8(10):1098-104 PMID: 12219084
  63. Chromatin organization of gammaherpesvirus latent genomes.
    Biochim Biophys Acta. 2010 Mar-Apr;1799(3-4):236-45 PMID: 19853673
  64. CTCF, a conserved nuclear factor required for optimal transcriptional activity of the chicken c-myc gene, is an 11-Zn-finger protein differentially expressed in multiple forms.
    Mol Cell Biol. 1993 Dec;13(12):7612-24 PMID: 8246978
  65. A promoter for the highly spliced EBNA family of RNAs of Epstein-Barr virus.
    J Virol. 1987 Nov;61(11):3424-30 PMID: 2822952
  66. Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein.
    Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):9131-5 PMID: 8090780
  67. EBNA1 can link the enhancer element to the initiator element of the Epstein-Barr virus plasmid origin of DNA replication.
    J Virol. 1992 Jan;66(1):489-95 PMID: 1309258
  68. Quantitative analysis of chromosome conformation capture assays (3C-qPCR).
    Nat Protoc. 2007;2(7):1722-33 PMID: 17641637
  69. Regulation of the transcription factor, CTCF, by phosphorylation with protein kinase CK2.
    FEBS Lett. 2005 Feb 28;579(6):1424-34 PMID: 15733852
Article Info
Journal
PLoS pathogens
Abbr.
PLoS Pathog
ISSN
1553-7374
Published
2011-07-00
Epub
2011-00-28
Pages
e1002180
Language
English
Region
United States
NLM ID
101238921
PMCID
PMC3145795
Subset
IM
Grants
NCI NIH HHS · P30 CA010815 · United States
NIDCR NIH HHS · R01 DE017336 · United States
NCI NIH HHS · 5 P30 CA 010815-41 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com